US nutrition startup Berry Street merges with India’s Healthify as GLP-1 trends upwards

The merger of Berry Street and Healthify creates a significant player in the digital health and GLP-1 support space, with a dual-brand strategy targeting both the U.S. and Indian markets. For India, this means Healthify, already a major player with 45 million customers, gains Berry Street's clinical infrastructure and insurance coverage expertise, potentially accelerating the adoption of GLP-1 aided programs. This could solidify Healthify's position as a leader in a rapidly evolving health tech segment within the region. The integration of AI-powered coaching with clinical networks is a model to watch. The key challenge for the combined entity will be seamlessly integrating Berry Street's U.S. clinical network with Healthify's AI and coaching platform, especially given the differing regulatory and insurance landscapes. While the U.S. market is projected to have 30 million people on GLP-1 by 2030, the growth trajectory in India and other Asian markets will depend heavily on local healthcare infrastructure, affordability, and regulatory acceptance of GLP-1 drugs and associated digital health services. The success of this merger will hinge on effective cross-market execution and adapting to diverse consumer needs.